What if you invested $1000 in LLY on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, Eli Lilly and Company has delivered an average annual return of 21.3%. The stock peaked in 2021 with a massive +69.4% gain, while investors faced a downturn in 2008 (-20.0%). Overall, the stock finished in the green 16 times out of 20 years.
Avg Return
+21.3%
Win Rate
80%
16W - 4L
Best
+69.4%
2021
Worst
-20.0%
2008
Performance Consistency
About Eli Lilly and Company
Visit Website ↗Eli Lilly and Company is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world.
Key Business Segments
Human Pharmaceutical Products
Discovery and development of medicines in oncology, diabetes, immunology, and neuroscience.
Key Innovations
- ✓First commercial insulin (Iletin)
- ✓Polio vaccine mass production
- ✓Prozac (fluoxetine)
- ✓Mounjaro/Zepbound (tirzepatide)
Historical Milestones
Founded by Colonel Eli Lilly.
Introduced the world's first commercial insulin.
Public listing on the NYSE.